Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.20 | 0.85% | 1,439.60 | 1,440.80 | 1,441.20 | 1,451.60 | 1,416.40 | 1,421.80 | 9,432,627 | 16:35:16 |
Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
---|---|---|---|---|---|
Pharmaceuticals & Biotechnology | 34,114.0 | 5,442.0 | 87.6 | 16.4 | 58,554 |
GSK PLC Block listing Interim Review
15/11/2022 4:00pm
UK Regulatory (RNS & others)
TIDMGSK
RNS Number : 4282G
GSK PLC
15 November 2022
BLOCK LISTING SIX MONTHLY RETURN
Date: 15 November 2022
Name of applicant: GSK plc Name of scheme: GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan -------------------------------------------------------- Period of return: From: 1 May 2022 To: 31 October 2022 ------------------------ --------------------- ------ ------------------------- Balance of unallotted securities under scheme(s) from previous return: 44,219 -------------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 -------------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 0 -------------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 44,219 -------------------------------------------------------- Name of applicant: GSK plc Name of scheme: GlaxoSmithKline plc Share Save Plan 2012 --------------------------------------------- Period of return: From: 1 May 2022 To: 31 October 2022 ------------------------ ----------------- ----- ------------------- Balance of unallotted securities under scheme(s) from previous return: 1,373,495 --------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 --------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 251,620 --------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 1,121,875 --------------------------------------------- Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 ---------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRDELBFLFLXFBB
(END) Dow Jones Newswires
November 15, 2022 11:00 ET (16:00 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |